These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13879017)

  • 1. Effectiveness of Cytoxan against intracerebrally and subcutaneously inoculated mouse lymphoid leukemia L1210.
    CHIRIGOS MA; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1962 Feb; 22():187-95. PubMed ID: 13879017
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM; HUMPHREYS SR; GOLDIN A
    Cancer Res; 1959 Oct; 19():986-95. PubMed ID: 13841661
    [No Abstract]   [Full Text] [Related]  

  • 3. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH; OETTGEN HF; LYMAN M; PURPLE J
    Acta Unio Int Contra Cancrum; 1964; 20():256-9. PubMed ID: 14151900
    [No Abstract]   [Full Text] [Related]  

  • 4. Some effects of cyclophosphamide (cytoxan) on normal mice and mice with L1210 leukemia.
    LANE M
    J Natl Cancer Inst; 1959 Dec; 23():1347-59. PubMed ID: 14413840
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathology of the spread of L1210 leukemia in the central nervous system of mice and effect of treatment with Cytoxan.
    THOMAS LB; CHIRIGOS MA; HUMPHREYS SR; GOLDIN A
    J Natl Cancer Inst; 1962 Jun; 28():1355-89. PubMed ID: 13920822
    [No Abstract]   [Full Text] [Related]  

  • 6. A new mouse ascites tumour to be used as a screening tool.
    NEMETH L; KELLNER B
    Neoplasma; 1961; 8():337-43. PubMed ID: 14478985
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. II. CHEMOTHERAPY OF VIRUS-INDUCED LYMPHOID LEUKEMIA.
    CHIRIGOS MA; RAUSCHER FJ; KAMEL IA; FANNING GR; GOLDIN A
    Cancer Res; 1963 Nov; 23():1646-50. PubMed ID: 14098904
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of Hodgkin's disease and the leukemias with cytoxan. II. Clinical reports, 1960-62.
    SAMPEY JR
    Am J Pharm Sci Support Public Health; 1962 Aug; 134():305-12. PubMed ID: 13976140
    [No Abstract]   [Full Text] [Related]  

  • 9. DISTRIBUTION AND EFFECTS OF 4', 4"-DI(2-IMIDAZOLIN-2-YL)TEREPHTHALANILIDE DIHYDROCHLORIDE HEMIHYDRATE AND ITS 2-CHLORO ANALOGUE IN LYMPHOCYTIC LEUKEMIAS L1210 AND P388.
    SIVAK A; ROGERS WI; WODINSKY I; KENSLER CJ
    J Natl Cancer Inst; 1964 Sep; 33():457-65. PubMed ID: 14207856
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a leukaemia resistant to cyclophosphamide ('Cytoxan').
    LANE M; YANCEY ST
    Nature; 1960 Nov; 188():756-7. PubMed ID: 13758721
    [No Abstract]   [Full Text] [Related]  

  • 11. CHEMOTHERAPY OF ADVANCED MOUSE LEUKEMIA L1210: COMPARISON OF METHOTREXATE ALONE AND IN SEQUENTIAL THERAPY.
    VENDITTI JM; GOLDIN A
    Cancer Res; 1964 Sep; 24():1457-60. PubMed ID: 14221802
    [No Abstract]   [Full Text] [Related]  

  • 12. [TREATMENT OF CHRONIC LYMPHATIC LEUKEMIA WITH A NEW ALKYLATING AGENT, CYCLOPHOSPHAMIDE].
    FARRERASVALENTI P; ROZMAN C; BLANCO F
    Rev Clin Esp; 1963 Oct; 91():17-22. PubMed ID: 14113319
    [No Abstract]   [Full Text] [Related]  

  • 13. Microspectrophotometry of the deoxyribonucleic acid in the thymus cells of leukaemic and normal AK mice following the application of aminopterin, azauridine, and phosphoramide in vivo.
    VESELY J; NEDVIDEK J; SEIFERT J
    Neoplasma; 1961; 8():371-8. PubMed ID: 13925621
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics and response to certain cancer chemotherapeutic agents of an acute lymphocytic leukemia arising in a BALB-c times DBA-2F1 mouse.
    Yancey ST; Bleyer WA
    Cancer Res; 1974 Aug; 34(8):1866-9. PubMed ID: 4526157
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the effectiveness of 4',4"-di-2-imidazolin-2-ylterephthalanilides against mouse leukemia L1210 and resistant variants.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1962 Jun; 19():5-11. PubMed ID: 13925303
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effectiveness of Tetramin and its components against advanced leukemia L1210 in mice.
    VENDITTI JM; GOLDIN A; KLINE I
    Cancer Chemother Rep; 1961 Apr; 11():73-6. PubMed ID: 13780696
    [No Abstract]   [Full Text] [Related]  

  • 17. The effectiveness of cyclophosphamide (cytoxan) against well established transplanted rodent tumors.
    LANE M
    Cancer Res; 1960 Sep; 20():1269-73. PubMed ID: 13758722
    [No Abstract]   [Full Text] [Related]  

  • 18. TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH CHLORAMBUCIL (NSC-3088) AND CYCLOPHOSPHAMIDE (NSC-26271).
    KAUNG DT; WHITTINGTON RM; PATNO ME
    Cancer Chemother Rep; 1964 Jul; 39():41-5. PubMed ID: 14201274
    [No Abstract]   [Full Text] [Related]  

  • 19. THE ACTIVITY OF A NEW ANTIMETABOLITE, 5-AZACYTIDINE, AGAINST LYMPHOID LEUKAEMIA IN AK MICE.
    SORM F; VESELY J
    Neoplasma; 1964; 11():123-30. PubMed ID: 14160691
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy of leukemia L1210 in mice with 1-beta-D-arabinofuranosylcytosine hydrochloride. II. Effectiveness against intracerebrally and subcutaneously inoculated leukemic cells.
    Kline I; Venditti JM; Tyrer DD; Mantel N; Goldin A
    Cancer Res; 1966 Sep; 26(9):1930-7. PubMed ID: 5924958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.